First Time Loading...

Gujarat Themis Biosyn Ltd
BSE:506879

Watchlist Manager
Gujarat Themis Biosyn Ltd Logo
Gujarat Themis Biosyn Ltd
BSE:506879
Watchlist
Price: 408.7 INR 0.99%
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one GUJTHEM stock under the Base Case scenario is 116.2 INR. Compared to the current market price of 408.7 INR, Gujarat Themis Biosyn Ltd is Overvalued by 72%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GUJTHEM Relative Value
Base Case
116.2 INR
Overvaluation 72%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

19
P/S
P/S
Price to Sales
19
vs History
0
vs Industry
10
Median 3Y
6.4
Median 5Y
1.1
Industry
2.4
More Details
54
P/E
P/E
Price to Earnings
54
vs History
0
vs Industry
7
Median 3Y
17.1
Median 5Y
2.9
Industry
22.9
More Details
51.6
P/OCF
P/OCF
Price to OCF
51.6
vs History
7
vs Industry
7
Median 3Y
24.4
Median 5Y
7.2
Industry
17.1
More Details
1 290.3
P/FCFE
P/FCFE
Price to FCFE
1 290.3
vs History
0
vs Industry
0
Median 3Y
66.6
Median 5Y
12.4
Industry
23.2
More Details
16.7
P/B
P/B
Price to Book Value
16.7
vs History
0
vs Industry
3
Median 3Y
6.7
Median 5Y
1.4
Industry
2.1
More Details
19
EV/S
EV/S
Enterprise Value to Sales
19
vs History
0
vs Industry
9
Median 3Y
6
Median 5Y
0.8
Industry
2.6
More Details
31.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
31.1
vs History
0
vs Industry
7
Median 3Y
7.7
Median 5Y
1
Industry
5.1
More Details
40.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
40.8
vs History
0
vs Industry
7
Median 3Y
12.2
Median 5Y
1.9
Industry
13.6
More Details
42.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
42.6
vs History
0
vs Industry
10
Median 3Y
12.6
Median 5Y
2
Industry
17
More Details
51.6
EV/OCF
EV/OCF
Enterprise Value to OCF
51.6
vs History
7
vs Industry
8
Median 3Y
24.3
Median 5Y
5.1
Industry
15.8
More Details
810.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
810.7
vs History
0
vs Industry
1
Median 3Y
62.4
Median 5Y
5.3
Industry
17.6
More Details
16.1
EV/IC
EV/IC
Enterprise Value to IC
16.1
vs History
0
vs Industry
7
Median 3Y
6.7
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

GUJTHEM Competitors Multiples
Gujarat Themis Biosyn Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Gujarat Themis Biosyn Ltd
BSE:506879
29.7B INR 19 54 40.8 42.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.4B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17 47.2 34.6 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
351.8B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.2B USD 5.5 910 45.2 88.2
UK
AstraZeneca PLC
LSE:AZN
185.8B GBP 5.1 39 140.5 225.4
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176.2B CHF 3 15.3 8.5 10

See Also

Summary
GUJTHEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
GUJTHEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GUJTHEM stock valuation using valuation multiples.
Wall Street Estimates
GUJTHEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GUJTHEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.